Browsing by Author "Cortés Castan, Javier"
Now showing items 1-20 of 63
-
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomás; Martin, Miguel; Fernández-Martínez, Aranzazu; Alba, Emilio; Rodríguez-Lescure, Álvaro; Cortés Castan, Javier; Paré, Laia (Frontiers Media, 2019-04-26) -
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Cortés Castan, Javier; Schmid, Peter (BMC, 2021-01-15) -
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Johnston, Stephen RD; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Cortés Castan, Javier (American Society of Clinical Oncology, 2020-12-01) -
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Harbeck, Nadia; Rastogi, P.; Martin, M.; Tolaney, Sara M; Shao, Zhi Min; Fasching, Peter A.; Cortés Castan, Javier (Elsevier, 2021-12) -
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Cortés Castan, Javier (MDPI, 2021-09) -
Antibody–drug conjugates: smart chemotherapy delivery across tumor histologies
Tarantino, Paolo; Carmagnani Pestana, Roberto; Corti, Chiara; Modi, Shanu; Bardia, Aditya; Tolaney, Sara M; Cortés Castan, Javier (Wiley, 2022-03) -
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge
de Melo Gagliato, Debora; Buzaid, Antonio C; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Cortés Castan, Javier (MDPI, 2020-09-01) -
Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
González-Martínez, Silvia; Pizarro, David; Pérez-Mies, Belén; Caniego-Casas, Tamara; Cortés Castan, Javier; Palacios, José; Curigliano, Giuseppe (MDPI, 2021-10-28) -
Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Porcu, Luca; Cortés Castan, Javier; Miceli, Rosalba; Di Cosimo, Serena; Malfettone, Andrea (Frontiers Media, 2020-07-10) -
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
Prat, Aleix; GUARNERI, VALENTINA; Brasó Maristany, Fara; Sanfeliu Torres, Esther; Paré, Laia; Cortés Castan, Javier; Pascual, Tomás; Vivancos, Ana (Elsevier, 2022-01) -
Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review
Huang, Min; Haiderali, Amin; Fox, Grace E.; Frederickson, Andrew; Cortés Castan, Javier; Fasching, Peter A.; O’Shaughnessy, Joyce (Springer, 2022-05) -
Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis
O’Shaughnessy, Joyce; Cortés Castan, Javier; Twelves, Chris; Goldstein, Lori J.; Alexis, Karenza; Xie, Ran (Nature Research, 2020-07-08) -
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
Im, Seock-Ah; Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe (American Medical Association, 2021-04) -
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Bidard, François-Clement; Kaklamani, Virginia; Neven, Patrick; Streich, Guillermo; Montero, Alberto J.; Forget, Frédéric; Cortés Castan, Javier (American Society of Clinical Oncology, 2022-10-01) -
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
González-Martínez, Silvia; Pérez-Mies, Belén; Pizarro, David; Caniego-Casas, Tamara; Cortés Castan, Javier; Palacios, José (MDPI, 2021-07) -
Epstein–Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report
Peg Camara, Vicente; Rabanal, Rosa Maria; Zamora Adelantado, Esther; Molina, Elisa; Arribas López, Joaquin Vicente; Cortés Castan, Javier; Bernadó Morales, Cristina; Aran Garriga, Andrea (Frontiers Media, 2021-11) -
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
Monti, Manuela; Degenhardt, Tom; Brain, Etienne; Wuerstlein, Rachel; Argusti, Alessandra; Puntoni, Matteo; Cortés Castan, Javier; Piris-Giménez, Alejandro (Frontiers Media, 2022-01) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
de Azambuja, Evandro; Trapani, Dario; Loibl, Sibylle; Delaloge, Suzette; Senkus, Elzbieta; Criscitiello, Carmen; Cortés Castan, Javier (BMJ, 2020-05-20) -
Evaluation of triple negative breast cancer with heterogeneous immune infiltration
ARENAS LAHUERTA, ENRIQUE JAVIER; Bernadó Morales, Cristina; Fernandez Navarro, Jose; Gonzalez Rodriguez, Jonatan; Moline, Teresa; Arribas, Joaquin; Quintana, Angela; Esteve-Codina, Anna; Peg, Vicente; Cortés Castan, Javier (Frontiers Media, 2023-05-04) -
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
Swain, Sandra; Macharia, Harrison; Cortés Castan, Javier; Dang, Chau; Hurvitz, Sara; Gianni, Luca (MDPI, 2022-10-15)